• news

• World news

• Europe

In Europe, the use of astrazenica vaccines is stopped, experts: there is no basis for concern

While the operation on the continent is faltering, Germany, France, Italy, Spain and other countries have suspended the use of this vaccine, following several cases of blood clots.

However, the World Health Organization and the European Medicines Agency have called for its continued use.

According to Astraznica, the prevalence of the phenomenon among vaccinators is smaller than usual

Tags

• The European Union

• Astraznica

• Vaccine for corona

• Corona virus

News agencies

Monday, 15 March 2021, 20:36 Updated: 21:45

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments

• The problem of wild boars on the streets of Haifa is getting worse: for the first time ...

• A man brutally beats a minor 14.03.21

• Parshat Zahav Zahav: Sources in the Magen organization that assisted in the investigation ...

• Elections in the Netherlands: Prime Minister on a test of dealing with ...

• Prof. Ash presented the outline for Passover: "No more expected ...

• Hundreds of teenagers demonstrated in front of the Tel Aviv State Attorney's Office ...

• A decade of war in Syria: 380,000 killed, 200,000 ...

• Bennett: Does not sanctify the role of Prime Minister, only deals ...

• Personal elections - Inon Magal in conversation with Minister Eli ...

In video: European countries stop use of Astraznica corona vaccines (Photo: Reuters)

Germany, France, Italy and Spain announced today (Monday) the suspension of the use of Astraznica corona vaccines, following a series of incidents across the continent involving blood clots.

They have joined several other EU countries that have already halted the use of vaccines, developed in collaboration with the British University of Oxford, in order to do further testing out of caution.

However, the World Health Organization said there was no basis for the same incidents being caused by the vaccine, which should be the hope of many countries for being cheaper and easier to transport and store than other vaccines developed in the West.

The organization's chairman said he will review the reports of adverse events related to these vaccines, but stressed the importance to continue to use them. Organization experts will meet tomorrow to discuss the vaccine.

Even the European Medicines Agency will meet tomorrow to discuss vaccines of Astrhznikh, and she will make a decision on them Thursday. as the World health organization, is called to continue to use them at this point. according to various experts, the number of incidents of blood clots appeared in vaccinated are not excessive when compared to the average of their total population.

according Astrhznikh, from about 17 million people who received the vaccine in the EU and UK, Less than 40 cases of blood clots have been reported in the past week.

More on Walla!

Chancellor Austria: Some European countries have "secret contracts" with vaccine companies

To the full article

for further reading

• In Europe, attempts are being made to accelerate the operation of the corona vaccine: "a battle that must not be lost"

• Speed ​​vs. Efficiency: Corona vaccine war between EU and UK

• The first aid button that accompanies anywhere and anytime

The World Health Organization will enter a discussion on the subject.

Nurse receiving AstraZenica vaccine in Zenfenberg, Germany (Photo: AP)

The cessation of the use of these vaccines, although only temporarily, increases the fear of a further slowdown in the union's vaccination campaign, which is already faltering.

The bloc's countries are suffering from a shortage of supply due to production problems, including of Astraznica.

In addition to Germany, France, Italy and Spain, some of the largest and most populous on the continent, the Netherlands, Denmark, Norway, Ireland, Bulgaria and Iceland also temporarily halted the use of these vaccines, while Austria suspended some shipments.

On the other hand, Poland, the Czech Republic and Ukraine have announced that they will continue to administer the Astraznica vaccine.

In the UK, Prime Minister Boris Johnson has said the vaccine is safe.

According to him, the regulation on drugs and vaccines in the kingdom is one of the toughest and most experienced in the world.

"They see no reason to stop the vaccination program," said Johnson, who expressed satisfaction with the vaccine rate in the kingdom, which is one of the highest in the world and by a considerable margin from the EU countries, from which Britain finally withdrew earlier this year.

A senior U.S. official, who has already approved three corona vaccines, said today that a group of experts is still testing the results of a trial of 30,000 people to determine if the vaccine is safe and effective.

The hope of many countries in the world.

Woman receiving AstraZenica vaccine in Milan (Photo: Reuters)

The situation in Europe is not alarming.

Germany warned last week that it was facing a third wave of illness, Italy announced it was tightening the closure at its borders and hospitals in the Paris area are approaching a state of overload.

German Health Minister Jens Schpan said that although the risk of blood clots was low, it could not be ruled out with certainty.

"This is a professional decision, not a political one," Pan said, adding that the decision was made following a recommendation from the Paul Ehrlich Institute, which is in charge of the immunization system in Germany.

France has announced that it is suspending the use of the vaccine until the European Medicines Agency's assessment, which is expected to be received on Tuesday.

"The decision taken, in accordance with our European policy, is to cautiously suspend the use of the vaccine, in the hope that we can resume its use quickly if the European Agency's directive allows," said French President Emmanuel Macron.

In Italy, it was said that stopping vaccines was a "temporary precaution" until the European Medicines Agency's decision.

"The agency will meet soon to find out all the doubts, so that the Asterzanica vaccine can be used again safely and the vaccination campaign can be continued as soon as possible," said a senior Italian health official.

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments